Package 42806-415-60

{"route": ["ORAL"], "spl_id": "af1a3522-8180-4e3f-a2fc-c9fe143997a3", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993503", "993518", "993536"], "spl_set_id": ["9fb44e96-6160-4a4a-90cb-91764c0dcd89"], "manufacturer_name": ["Epic Pharma LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-415-01)", "package_ndc": "42806-415-01", "marketing_start_date": "20211215"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-415-05)", "package_ndc": "42806-415-05", "marketing_start_date": "20211215"}, {"sample": false, "description": "250 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-415-52)", "package_ndc": "42806-415-52", "marketing_start_date": "20211215"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-415-60)", "package_ndc": "42806-415-60", "marketing_start_date": "20211215"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "42806-415_af1a3522-8180-4e3f-a2fc-c9fe143997a3", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "42806-415", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Epic Pharma LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA075932", "marketing_category": "ANDA", "marketing_start_date": "20211215", "listing_expiration_date": "20261231"}